As of 2024-12-11, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.0x - 13.8x | 11.8x |
| Forward P/E multiples | 11.4x - 24.8x | 16.9x |
| Fair Price | (14.00) - (16.25) | (16.82) |
| Upside | -173.7% - -185.5% | -188.5% |
| Date | EV/EBITDA |